StockData
Abbott Laboratories logo

Abbott Laboratories (ABT) operating KPIs

ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)

Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%

Abbott Laboratories u.S. FDA MAUDE Adverse Event MDR Reports — Abbott Total

U.S. FDA openFDA MAUDE Post-Market Surveillance API

QuarterlyAnnualMonthly
Latest, Q3 2026
295,931
Period ended Sep 30, 2026
Change on a year earlier
+1,069.8%
25,298 in Q3 2025
History
51 quarters
Since Q1 2014
Sources
1
U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedU.S. FDA MAUDE Adverse Event MDR Reports — Abbott TotalYear on yearSource
Q3 2026Sep 30, 2026295,931+1,069.8%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q2 2026Jun 30, 2026143,866+515.1%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q1 2026Mar 31, 202629,400+40.1%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q4 2025Dec 31, 202523,684+5.9%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q3 2025Sep 30, 202525,298+1.2%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q2 2025Jun 30, 202523,390+4.8%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q1 2025Mar 31, 202520,979+2.5%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q4 2024Dec 31, 202422,373+1.2%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q3 2024Sep 30, 202425,010+2.0%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q2 2024Jun 30, 202422,310-10.7%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q1 2024Mar 31, 202420,460-9.1%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q4 2023Dec 31, 202322,102-0.4%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q3 2023Sep 30, 202324,527+2.5%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q2 2023Jun 30, 202324,983+21.1%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q1 2023Mar 31, 202322,516+13.6%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Q4 2022Dec 31, 202222,186+12.6%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗

Breakdown

What makes up u.s. fda maude adverse event mdr reports — abbott total

Cite this data

StockData. (2026). Abbott Laboratories U.S. FDA MAUDE Adverse Event MDR Reports — Abbott Total, quarterly Q1 2014–Q3 2026 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/ext-fda-maude-tot

See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.